Tafinlar 10 mg, Tablette zur Herstellung einer Suspension zum Einnehmen
7680691350016
CH-69135
Tablette
Associated product:
TAFINLAR cpr disp 10 mg fl 210 pce
1 / 3
google
Article details
- Package size
- 210
- Selling units
- 210
- Measure
- Tablette(n)
- Galenic form
- Tablette
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
dabrafenibum
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
dabrafenibi mesilas
|
- | Substance | WIZUS |
|
mannitolum
|
- | Substance | HNIDK |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
crospovidonum
|
- | Substance | HNIDK |
|
hypromellosum
|
- | Substance | HNIDK |
|
acesulfamum kalicum
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
aromatica
|
- | Substance | AROMA |
|
alcohol benzylicus
|
0.00078 MG | Substance | HBESI |
|
propylenglycolum
|
0.036 MG | Substance | HBESI |
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 69135
- Drug name
- Tafinlar, Tablette zur Herstellung einer Suspension zum Einnehmen
- Galenic form
- TABSU
- ATC Code
- L01EC02
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 05/09/2023
- Authorization expiration date
- 04/09/2028
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- TAFINLAR cpr disp 10 mg fl 210 pce
- Description (DE)
- TAFINLAR Disp Tabl 10 mg Fl 210 Stk
- Market launch
- 05/09/2023
- Narcotic (BTM)
- No